FDA Quality Office Looks Back At 2017: Reviews Accelerated, Inspections Realigned
US agency's Office of Pharmaceutical Quality continues to accelerate review and inspection processes, according to its first annual report. Meanwhile, the office's signature quality metrics initiative goes underground.